<PAGE>
EXHIBIT 99
FOR IMMEDIATE RELEASE
OCTOBER 25, 2000
Option Care, Inc. Announces APPOINTMENT OF CARLA M. PONDEL
AS CHIEF FINANCIAL OFFICER
Bannockburn, Ill, October 25, 2000, Option Care, Inc. (Nasdaq: OPTN),
announced today the appointment of Carla M. Pondel as Chief Financial
Officer. She joins the company with more than 15 years of broad financial
management experience. Pondel will be replacing Mr. Michael Siri, the
company's current Chief Financial Officer, who is leaving to pursue other
opportunities.
Prior to her appointment, Ms. Pondel spent nearly 10 years with Baxter
International, Inc. where she most recently held the position of Director of
Global Finance for its $2.7 billion IV Systems Division. In this capacity,
she was responsible for the strategic and operations plans. Carla has also
previously served in various senior finance capacities for Pathogenesis
Corporation, a biotech pharmaceutical corporation, Boise Cascade, a leading
$3 billion distributor of office products and Caremark International, a $4.8
billion health care company. Carla has an MBA degree in Finance from
Northwestern University's J.L. Kellogg Graduate School of Management.
Raj Rai, President and Chief Operating Officer of Option Care stated, "I
would like to thank Mike for his valuable contribution to Option Care over
the last couple of years. Mike will stay on until the end of the month to
assist in a smooth transition."
Rai further stated, "We are pleased to be able to attract a senior level
executive of Carla's caliber to join the Option Care team. Her extensive
financial experience will be vital to our ongoing efforts to grow our
revenues and essential to solidifying our position as a leading provider of
specialty pharmacy products and services. Carla is a demonstrated leader and
team player who will be a valuable addition to our organization."
"I am excited to be joining Option Care. There are a number of important
opportunities including acquisitions, new agreements with managed care
organizations and biotechnology manufacturers where my financial experience
can play a key role. Option Care is in an exciting position as a leading
corporation in infusion and specialty pharmacy to fulfill the needs of
managed care and bio-pharmaceutical distribution channels" said Pondel, "I
look forward to being part of the team that will drive and manage this
company into the future."
Option Care is a provider of specialty pharmacy products and services for
injectable and intravenous delivery. The Company contracts with managed care
organizations and other third party payers to distribute pharmaceutical
products and complex compounded solutions through its national network of 131
service locations for delivery to physicians offices or administration to
patients at home or an alternate site setting. Option Care, through its
OptionMed subsidiary, provides direct-to-physician and direct-to-patient
specialty pharmacy products and services through managed care contracts.
Option Care also operates a wholly owned subsidiary, Management By
Information, Inc. (MBI), which designs state-of-the-art data management
products and services for the home health industry. Additional information
can be found on the companies' websites at www.optioncare.com and
www.mbimbi.com.
